Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell, Lowell, MA, USA.
Department of Mathematical Sciences, University of Massachusetts Lowell, Lowell, MA, USA.
J Nutr. 2020 Dec 10;150(12):3231-3240. doi: 10.1093/jn/nxaa253.
Low vitamin D status, assessed using serum 25-hydroxyvitamin D [25(OH)D] concentration, has been associated with depression, but research among minority populations, such as Puerto Ricans is limited. We examined the association between serum 25(OH)D and self-reported depressive symptomatology across 3 waves of follow-up in a cohort of Puerto Rican adults residing in Massachusetts.
We evaluated the cross-sectional and longitudinal associations between serum 25(OH)D and self-reported depressive symptoms in the Boston Puerto Rican Health Study (BPRHS) cohort.
Participants of the BPRHS were evaluated for depressive symptoms using the Center for Epidemiologic Studies Depression Scale (CES-D). Serum 25(OH)D was measured at baseline (n = 1434), year 2 (n = 1218), and year 5 (n = 914). We categorized serum 25(OH)D concentration as sufficient (≥20 ng/mL), insufficient (12 to <20 ng/mL), and deficient (<12 ng/mL). Multivariable linear regression was used for cross-sectional analyses at baseline, and repeated measures mixed effects modeling was used over 3 waves of follow-up for longitudinal analyses. We conducted sensitivity analyses in vitamin D supplement nonusers and participants with complete data on baseline serum 25(OH)D and CES-D at all 3 visits.
Serum 25(OH)D concentration was not associated with CES-D score in cross-sectional analysis [β = -0.85; 95% CI: -2.80, 1.10 for deficient compared with sufficient 25(OH)D; P-trend = 0.59] or in longitudinal analyses over 5 y [β = -0.41; 95% CI: -1.95, 1.13 for deficient compared with sufficient 25(OH)D; P-trend = 0.93]. Results were similar in sensitivity analyses restricted to vitamin D supplement nonusers (n = 1371) and in analyses conducted in participants with complete measures of baseline serum 25(OH)D and CES-D score at all 3 visits (n = 887) [β = -0.12; 95% CI: -1.98, 1.74 for deficient compared with sufficient 25(OH)D; P-trend = 0.93].
We did not observe a significant association between serum 25(OH)D and depressive symptomatology in the BPRHS cohort.
使用血清 25-羟维生素 D [25(OH)D] 浓度评估的维生素 D 状态较低与抑郁症有关,但针对波多黎各等少数族裔人群的研究有限。我们在马萨诸塞州居住的波多黎各成年人队列中,通过 3 次随访检查了血清 25(OH)D 与自我报告的抑郁症状之间的关联。
我们评估了波士顿波多黎各健康研究(BPRHS)队列中血清 25(OH)D 与自我报告的抑郁症状之间的横断面和纵向关联。
使用流行病学研究中心抑郁量表(CES-D)评估 BPRHS 参与者的抑郁症状。在基线(n=1434)、第 2 年(n=1218)和第 5 年(n=914)测量血清 25(OH)D。我们将血清 25(OH)D 浓度分类为充足(≥20ng/mL)、不足(12 至<20ng/mL)和缺乏(<12ng/mL)。在基线的横断面分析中使用多变量线性回归,在 3 次随访的重复测量混合效应模型中进行纵向分析。我们在维生素 D 补充剂非使用者和在所有 3 次就诊时均具有完整基线血清 25(OH)D 和 CES-D 数据的参与者中进行了敏感性分析。
在横断面分析中,血清 25(OH)D 浓度与 CES-D 评分无关[β=-0.85;与充足 25(OH)D 相比,缺乏的 25(OH)D 的 95%CI:-2.80,1.10;P 趋势=0.59]或在 5 年的纵向分析中[β=-0.41;与充足 25(OH)D 相比,缺乏的 25(OH)D 的 95%CI:-1.95,1.13;P 趋势=0.93]。在仅包括维生素 D 补充剂非使用者(n=1371)的敏感性分析中以及在所有 3 次就诊时均具有完整的基线血清 25(OH)D 和 CES-D 评分的参与者(n=887)的分析中,结果相似[β=-0.12;与充足 25(OH)D 相比,缺乏的 25(OH)D 的 95%CI:-1.98,1.74;P 趋势=0.93]。
我们在 BPRHS 队列中未观察到血清 25(OH)D 与抑郁症状之间存在显著关联。